ARCHIVES

Studies Link Age-Dependent Outcome To Immune Cells

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

FDA Approves Taxotere And Gemzar; Sends Approvable Letter For Etopophos

May 24, 1996

Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years

April 25, 2014

DCPC Advisors OK Expansion Of Science Enrichment Program, Other Concepts

November 1, 1991

NIH offers student loan repayment program, deadline is Dec. 31.

November 21, 2003

In The Courts: Lilly’s Claims Figured In Scripts Written To Coach Sales res, Court Documents Show

July 30, 1999

Conversation with The Cancer Letter: Scott Soefje: “These are Life-Saving Drugs. I’m Not Going To Stop Treating Patients, Right?”

October 3, 2014